title: New pathogenic mechanisms in Burkitt lymphoma.
abstract: Two studies in this issue identify the landscape of somatic mutations in Burkitt lymphoma and highlight the pathogenic and clinical relevance of inactivating mutations of ID3, an inhibitor of the TCF3 transcription factor.
authors.affiliation: Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain. ecampo@clinic.ub.es
authors.forename: Elias
authors.initials: E
authors.lastname: Campo
mesh_terms: D002051:Burkitt Lymphoma / Q000235:genetics / Q000473:pathology*; D006801:Humans; D051796:Inhibitor of Differentiation Proteins / Q000235:genetics; D009154:Mutation; D009363:Neoplasm Proteins / Q000235:genetics
chemical_list: D051796:Inhibitor of Differentiation Proteins; D009363:Neoplasm Proteins; C075640:ID3 protein, human